Trial Profile
HIV Pre-Exposure Prophylaxis Priming of Immune Effectors
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Biomarker; Pharmacodynamics
- Acronyms PREPPIE
- 18 Sep 2017 Status changed from not yet recruiting to recruiting.
- 05 Nov 2015 New trial record